It can be concluded that icariin has significant anti-inflammatory effects on CS induced COPD mice and CSE-induced cell models, and the anti-inflammatory effect is likely achieved by inhibiting the NF-kB pathway. This evidence concerns the gene NFKB1 and chronic obstructive pulmonary disease.